BPBenjamin Post

Benjamin Post

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Benjamin Post has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Combining multimorbidity clustering with limited demographic information enables high-precision outcome predictions

    by Fabio S. Ferreira, Erwann Le Lannou, Benjamin Post, Shlomi Haar, Balasundaram Kadirvelu, Stephen J. Brett, A. Aldo Faisal

    Multimorbidity, the coexistence of multiple health conditions in individuals, is prevalent and increasing worldwide, proving to be a growing challenge for patients and the healthcare systems. Furthermore, the prevalence of multimorbidity contributes to an increased risk of hospital admission or even death. In this study, we employ a principled approach that utilises longitudinal data routinely collected in electronic health records linked to half a million people from the UK biobank to generate digital comorbidity fingerprints (DCFs) using a topic modelling approach, Latent Dirichlet Allocation. These comorbidity fingerprints summarise a patient’s full secondary care clinical history, i.e. their comorbidities and past interventions. We identified 18 clinically relevant DCFs, which captured nuanced combinations of diseases and risk factors, e.g. grouping cardiovascular disorders with common risk factors but also novel groupings that are not obvious and differ in both their breadth and depth from existing observational disease associations. The DCFs, combined with demographic characteristics, performed on par or outperformed traditional models of all-cause mortality or hospital admission, showcasing the potential of data-driven strategies in healthcare forecasting. The comorbidity fingerprints together with age and number of hospital admissions were shown to be the most important factors in the predictions. Additionally, our DCF approach showed robust and consistent performance over time. Our findings underscore the promising role of interpretable data-driven approaches in healthcare forecasting, suggesting improved risk profiling for individual clinical decisions and targeted public health interventions, with consistent and robust performance over time. Author summary: This study addresses the global challenge of multimorbidity, the presence of multiple health conditions in individuals, which is on the rise and poses a significant burden on patients and healthcare systems. Investigating its impact on the risk of hospitalization or mortality, we employ a sophisticated approach using longitudinal data from the UK Biobank to create digital comorbidity fingerprints (DCFs) through natural language processing methods. These DCFs, summarizing a patient’s complete clinical history, reveal 18 clinically relevant patterns, including unique combinations of diseases and risk factors. When combined with patient demographic and lifestyle data, the DCF approach performs similarly to traditional models in predicting all-cause mortality or hospitalization. Notably, the DCF approach demonstrates robust and consistent performance over time, highlighting its potential for enhancing healthcare forecasting. These findings emphasize the value of interpretable data-driven strategies in healthcare, offering improved risk profiling for individual clinical decisions and targeted public health interventions with enduring reliability.

  • Open Access

    “I’d rather wait and see what’s around the corner”: A multi-perspective qualitative study of treatment escalation planning in frailty

    by Adam Lound, Jane Bruton, Kathryn Jones, Nira Shah, Barry Williams, Jamie Gross, Benjamin Post, Sophie Day, Stephen J. Brett, Helen Ward

    Introduction: People living with frailty risk adverse outcomes following even minor illnesses. Admission to hospital or the intensive care unit is associated with potentially burdensome interventions and poor outcomes. Decision-making during an emergency is fraught with complexity and potential for conflict between patients, carers and clinicians. Advance care planning is a process of shared decision-making which aims to ensure patients are treated in line with their wishes. However, planning for future care is challenging and those living with frailty are rarely given the opportunity to discuss their preferences. The aim of the ProsPECT (Prospective Planning for Escalation of Care and Treatment) study was to explore perspectives on planning for treatment escalation in the context of frailty. We spoke to people living with frailty, their carers and clinicians across primary and secondary care. Methods: In-depth online or telephone interviews and online focus groups. The topic guide explored frailty, acute decision-making and planning for the future. Data were thematically analysed using the Framework Method. Preliminary findings were presented to a sample of study participants for feedback in two online workshops. Results: We spoke to 44 participants (9 patients, 11 carers and 24 clinicians). Four main themes were identified: frailty is absent from treatment escalation discussions, planning for an uncertain future, escalation in an acute crisis is ‘the path of least resistance’, and approaches to facilitating treatment escalation planning in frailty. Conclusion: Barriers to treatment escalation planning include a lack of shared understanding of frailty and uncertainty about the future. Emergency decision-making is focussed on survival or risk aversion and patient preferences are rarely considered. To improve planning discussions, we recommend frailty training for non-specialist clinicians, multi-disciplinary support, collaborative working between patients, carers and clinicians as well as broader public engagement.


  • Open Access

    Breaking bad news in the era of artificial intelligence and algorithmic medicine: an exploration of disclosure and its ethical justification using the hedonic calculus

    by Benjamin Post, Cosmin Badea, Aldo Faisal, Stephen J. Brett

    An appropriate ethical framework around the use of Artificial Intelligence (AI) in healthcare has become a key desirable with the increasingly widespread deployment of this technology. Advances in AI hold the promise of improving the precision of outcome prediction at the level of the individual. However, the addition of these technologies to patient–clinician interactions, as with any complex human interaction, has potential pitfalls. While physicians have always had to carefully consider the ethical background and implications of their actions, detailed deliberations around fast-moving technological progress may not have kept up. We use a common but key challenge in healthcare interactions, the disclosure of bad news (likely imminent death), to illustrate how the philosophical framework of the 'Felicific Calculus' developed in the eighteenth century by Jeremy Bentham, may have a timely quasi-quantitative application in the age of AI. We show how this ethical algorithm can be used to assess, across seven mutually exclusive and exhaustive domains, whether an AI-supported action can be morally justified.


  • Open Access

    Clustering of patient comorbidities within electronic medical records enables high-precision COVID-19 mortality prediction

    by Aldo Faisal, Erwann Le Lannou, Benjamin Post, Shlomi Haar, Stephen Brett, Balasundaram Kadirvelu

    We present an explainable AI framework to predict mortality after a positive COVID-19 diagnosis based solely on data routinely collected in electronic healthcare records (EHRs) obtained prior to diagnosis. We grounded our analysis on the ½ Million people UK Biobank and linked NHS COVID-19 records. We developed a method to capture the complexities and large variety of clinical codes present in EHRs and we show that these have a larger impact on risk than all other patient data but age. We use a form of clustering for natural language processing of the clinical codes, specifically, topic modelling by Latent Dirichlet Allocation (LDA), to generate a succinct digital fingerprint of a patient’s full secondary care clinical history, i.e. their comorbidities and past interventions. These digital comorbidity fingerprints offer immediately interpretable clinical descriptions that are meaningful, e.g. grouping cardiovascular disorders with common risk factors but also novel groupings that are not obvious. The comorbidity fingerprints differ in both their breadth and depth from existing observational disease associations in the COVID-19 literature. Taking this data-driven approach allows us to avoid human-induction bias and confirmation bias during selection of what are important potential predictors of COVID-19 mortality. Together with age these digital fingerprints are the single most important factor in our predictor. This holds the potential for improving individual risk profiling for clinical decisions and the identification of groups for public health interventions such as vaccine programmes. Combining our digital precondition fingerprints with demographic characteristics allow us to match or exceed the performance of existing state-of-the-art COVID-19 mortality predictors (EHCF) which have been developed through expert consensus. Our precondition fingerprinting and entire mortality prediction analytics pipeline are designed so as to be rapidly redeployable, e.g. for COVID-19 variants or other pre-existing diseases.


  • Open Access

    Clustering of patient comorbidities within electronic medical records enables high-precision COVID-19 mortality prediction

    by Erwann Le Lannou, Benjamin Post, Shlomi Haar, Stephen J. Brett, Balasundaram Kadirvelu, A. Aldo Faisal

    We present an explainable AI framework to predict mortality after a positive COVID-19 diagnosis based solely on data routinely collected in electronic healthcare records (EHRs) obtained prior to diagnosis. We grounded our analysis on the ½ Million people UK Biobank and linked NHS COVID-19 records. We developed a method to capture the complexities and large variety of clinical codes present in EHRs, and we show that these have a larger impact on risk than all other patient data but age. We use a form of clustering for natural language processing of the clinical codes, specifically, topic modelling by Latent Dirichlet Allocation (LDA), to generate a succinct digital fingerprint of a patient’s full secondary care clinical history, i.e. their comorbidities and past interventions. These digital comorbidity fingerprints offer immediately interpretable clinical descriptions that are meaningful, e.g. grouping cardiovascular disorders with common risk factors but also novel groupings that are not obvious. The comorbidity fingerprints differ in both their breadth and depth from existing observational disease associations in the COVID-19 literature. Taking this data-driven approach allows us to avoid human-induction bias and confirmation bias during selection of what are important potential predictors of COVID-19 mortality. Together with age, these digital fingerprints are the single most important factor in our predictor. This holds the potential for improving individual risk profiling for clinical decisions and the identification of groups for public health interventions such as vaccine programmes. Combining our digital precondition fingerprints with demographic characteristics allow us to match or exceed the performance of existing state-of-the-art COVID-19 mortality predictors (EHCF) which have been developed through expert consensus. Our precondition fingerprinting and entire mortality prediction analytics pipeline are designed so as to be rapidly redeployable, e.g. for COVID-19 variants or other pre-existing diseases.


  • Open Access

    The Association between Supraphysiologic Arterial Oxygen Levels and Mortality in Critically Ill Patients: A Multicenter Observational Cohort Study

    by Edward Palmer, Benjamin Post, Roman Klapaukh, Giampiero Marra, Niall S. MacCallum, David Brealey, Ari Ercole, Andrew Jones, Simon Ashworth, Peter Watkinson, et al.

    Rationale: There is conflicting evidence on harm related to exposure to supra-physiologic arterial oxygen tensions (hyperoxemia) in critically ill patients. Objectives: To examine the association between longitudinal exposure to hyperoxemia and mortality in patients admitted to intensive care units (ICUs) in 5 UK University Hospitals. Methods: Retrospective cohort of ICU admissions between 31st January 2014 - 31st December 2018, from the National Institute of Health Research Critical Care Health Informatics Collaborative (CC-HIC). Multivariable logistic regression modelled death in ICU by exposure to hyperoxemia. Measurements: Subsets with oxygen exposure windows of 0-1, 0-3, 0-5 and 0-7 days were evaluated, capturing 19,515, 10,525, 6,360 and 4,296 patients, respectively. Hyperoxemia dose was defined as the area between the PaO2 time curve and a boundary of 13.3 kPa (100 mmHg) divided by the hours of potential exposure (24, 72, 120, or 168 hours). Main Results: An association was found between exposure to hyperoxemia and ICU mortality [odds ratios (95% compatibility intervals); 1.15 (0.95-1.38), p = 0.15; 1.35 (1.04-1.74), p = 0.02; 1.5 (1.07-2.13), p = 0.02; and 1.74 (1.11-2.72), p = 0.02 for exposure windows of 0-1, 0-3, 0-5 and 0-7 days’ duration, respectively. However, a dose-response relationship was not observed. There was no evidence to support a differential effect between hyperoxemia and either a respiratory diagnosis or mechanical ventilation. Conclusions: An association between hyperoxemia and mortality was observed in our large, unselected multicenter cohort. The absence of a dose-response relationship weakens causal interpretation. Further experimental research is warranted to elucidate this important question.